We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Technique for Creating Artificial Antibodies

By Biotechdaily staff writers
Posted on 29 Jul 2002
A new technique for creating artificial antibodies can be applied to many molecules and molecular recognition tasks, including organic catalysts, medical diagnostics, and sensors for chemical warfare agents. More...
The technique was described in the July 25, 2002, issue of Nature.

A disadvantage of conventional polymer imprinting is that each antigen or template molecule produces an artificial antibody containing all kinds of different binding sites, most of which have poor recognition abilities and are not effective. In the new technique, researchers attach dendrons to a porphyrin core to create a dendrimer. The flexible dendrimer scaffolding is then cross-linked in a chemical reaction that stitches together the end groups of the dendrons. Finally, a hydrolysis reaction chemically clips out the core, leaving a hollow space that can selectively and tightly bind appropriately shaped molecules.

"Upon removal of the template, we have a synthetic molecular shell that can bind specifically shaped molecules and reject all others, just like a natural antibody,” said Prof. Steven C. Zimmerman, of the University of Illinois at Urbana-Champaign (USA), a co-leader of the research team.

One of the researchers likens the process to the lost-wax process used in metal casting. "In essence, we are molding this dendrimer around our template and creating a rigid cast that functions like a molecular lock for a molecular key,” noted Prof. Kenneth S. Suslick, also a co-leader of the research team.


Related Links:
University of Illinois

New
Gold Member
Aspiration System
VACUSAFE
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Electrolyte Analyzer
BKE-B
New
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.